Edition:
United States

People: Alere Inc (ALR_pb.N)

ALR_pb.N on New York Stock Exchange

398.25USD
21 Sep 2017
Change (% chg)

$-0.75 (-0.19%)
Prev Close
$399.00
Open
$399.00
Day's High
$399.00
Day's Low
$398.25
Volume
200
Avg. Vol
1,229
52-wk High
$400.00
52-wk Low
$292.00

Nawana, Namal 

Mr. Namal Nawana serves as President, Chief Executive Officer, Director of the Company. He joined the company as Chief Operating Officer in December 2012 before being named Interim Chief Executive Officer in July 2014. Before coming to Alere, Mr. Nawana spent 15 years at Johnson & Johnson in various leadership roles. Most recently, he served as the Worldwide President of DePuy Synthes Spine, a Johnson & Johnson company, from February 2011 to November 2012. Prior to that, Mr. Nawana served as Area Vice President for Johnson & Johnson Medical in Australia and New Zealand from January 2009 to February 2011, Chairman of the DePuy Asia Pacific Franchise Council, General Manager for DePuy Australia from 2007 to December 2008 and General Manager for DePuy Canada from 2004 to 2007. Mr. Nawana holds an Honors Degree in Mechanical Engineering and a Master’s degree in Medical Science from the University of Adelaide, South Australia, and an MBA from Henley Management College. He is a member of the Board of Directors of Advamed Dx, a diagnostics industry organization, and the Board of Directors of Malaria No More.

Basic Compensation

Total Annual Compensation, USD 1,069,690
Restricted Stock Awards, USD 7,499,960
Long-Term Incentive Plans, USD --
All Other, USD 4,669
Fiscal Year Total, USD 8,574,310

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gregg Powers

289,965

Namal Nawana

8,574,310

James Hinrichs

2,868,380

Daniella Cramp

2,113,670

Sanjay Malkani

2,217,100

Avi Pelossof

2,114,960
As Of  30 Dec 2016